With the increased incidence of early-stage breast cancer detection, intra-operative tumor localization has become essential for optimal breast-conserving surgery. We provide the next generation of accurate and hassle-free tumor localization for breast cancer. The Magnetic Marker Localization (MaMaLoc) technology was developed at the Netherlands Cancer Institute, Amsterdam (NKI-AvL) in co-operation with the University of Twente. Its accurate, cost-efficient and simple nature provides clear benefits for patients, surgeons, and clinics alike.
Bram Schermers | firstname.lastname@example.org